BPC-157, the stable gastric pentadecapeptide, accelerated tissue repair across thirty-plus preclinical studies through a VEGFR2-Akt-eNOS angiogenic mechanism. A cited research console of the pathway, the pharmacokinetics, and the human-data gap.